The human meaning all of our microbes’ genes — reshape theof and . Following the human genome project, technological advancements have brought us much closer to acute precision in disease diagnosis and treatment.
How will microbiomes reshape what we eat?
Earlier this year, two researchers from the Weizmann Institute of Science published the results of a study from the Personalized Nutrition Project that looks at how individuals respond differently to food, based in part on the different microbiomes they host. The results found that there is no item of food whose effects are predictably universal for everyone, and that nutrition recommendations should be .
Diagnostics using the microbiome
One company applying the to cancer diagnostics is Metabiomics, an early-stage molecular diagnostics company. Metabiomics is focused on creating a non-invasive stool test that analyzes the human gut for the earlier and more accurate identification of colon polyps and colorectal cancer. Developments in and the unique nature of the human offers an opportunity for Big Pharma to develop devices that no adjacent industry has the expertise to develop.
Microbiome innovation spotlight: Enterome and Evolve Biosystems
Microbes serve to defend against disease and strengthen the immune system, so disease prevention is a natural fit for innovation. Prevention represents a massive opportunity for healthcare companies — the probiotics market be worth over $50 billion by 2020.
Therapeutics and diagnostics are two key applications for research.
What to expect in the future